NAPA COUNTY EMS AGENCY

Epinephrine MEDICATION REFERENCE CARD

• Cardiac arrest (adult/pediatric) • Allergic reaction/anaphylaxis • Pediatric Bradycardia • Respiratory Distress/Bronchospasm INDICATION

- • Cocaine-induced VT

• Infusion with alkaline solutions CONTRA INDICATION

• Anxiety • Weakness

• Apprehensiveness • Dizziness

SIDE • Restlessness • Palpitations

EFFECTS • Tremors • Headache C-02: Asystole/Pulseless Electrical Activity M-03: Respiratory Distress - Bronchospasm • 1mg IV/IO q 3-5 min 1:10,000 • 0.3 mg IM 1:1,000. May repeat x 2 at 10 minute intervals as clinically C-03: Ventricular Fibrillation/Pulseless Ventricular indicated Tachycardia

• 1mg IV/IO q 3-5 min 1:10,000 M-07: Allergic Reaction/Anaphylaxis C-04: Symptomatic Bradycardia • 0.3 mg IM 1:1,000. May repeat x 2 at

• 10mcg IV/IO 1:10,000 every 1-3 minutes. 10 minute intervals as clinically Repeat as necessary to maintain a systolic indicated blood pressure > 90mmHg. See mixing DOSE • 0.1 mg IV/IO 1:10,000. May repeat ADULT instructions for Push-Dose Epinephrine AP- once in 10 minutes as clinically 16. indicated C-08: Cardiogenic Shock • 10mcg IV/IO 1:10,000 every 1-3 minutes. Repeat as necessary to maintain a systolic blood pressure > 90mmHg. See mixing instructions for Push-Dose Epinephrine AP- 16.

• See Pediatric Medication Reference Cards (1:1,000)

ATRIC • See Pediatric Medication Reference Cards (1:10,000) • See Pediatric Cardiac Arrest Dosing Reference Cards PEDI

• Myocardial O2 requirements are • High doses produce vasoconstriction and increased may compromise organ function • Subcutaneous administration is not • Low doses may increase cardiac output with recommended for treatment of redirection of blood flow to skeletal muscles, CAUTION anaphylaxis because absorption is producing decreased renal blood flow delayed

S • Increases heartrate and automaticity • Increases system vascular resistance • Increases cardiac contractile force. • Increases blood pressure • Increases myocardial electrical activity • Causes bronchodilation ACTION

Effective Date: 01-01-2018 Revised Date: 01-01-2020 Page 1 of 2 • C-02: Asystole/Pulseless Electrical Activity • P-02: Pediatric Asystole/Pulseless Electrical Activity • Ventricular Fibrillation/Pulseless

C-03: Ventricular Tachycardia • P-03: Pediatric Ventricular Fibrillation/Pulseless Ventricular • C-04: Symptomatic Bradycardia Tachycardia • C-08: Cardiogenic Shock GUIDELINE • P-04: Neonatal Resuscitation • M-03: Respiratory Distress – Bronchospasm • P-06: Pediatric Symptomatic • M-07: Allergic Reaction/Anaphylaxis Bradycardia

Page 2 of 2